These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease. Selkoe DJ Handb Clin Neurol; 2008; 89():245-60. PubMed ID: 18631749 [No Abstract] [Full Text] [Related]
28. Lipids on the pathomechanisms of amyloid diseases. Ramamoorthy A Chem Phys Lipids; 2021 Sep; 239():105122. PubMed ID: 34375659 [No Abstract] [Full Text] [Related]
29. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207 [TBL] [Abstract][Full Text] [Related]
31. [Biochemistry study on brain pathology in Alzheimer's disease. Biochemical approach to the etiological mechanism]. Nukina N Nihon Rinsho; 1988 Jul; 46(7):1475-83. PubMed ID: 3065524 [No Abstract] [Full Text] [Related]
32. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. Guillemin GJ; Brew BJ Redox Rep; 2002; 7(4):199-206. PubMed ID: 12396664 [TBL] [Abstract][Full Text] [Related]
33. The neurobiology of isoprostanes and Alzheimer's disease. Praticò D Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452 [TBL] [Abstract][Full Text] [Related]
34. Linking transcription to physiology in lipidomics. Crestani M; Moschetta A Biochim Biophys Acta; 2015 Jan; 1851(1):1. PubMed ID: 25449651 [No Abstract] [Full Text] [Related]
35. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease. Shin J Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001 [No Abstract] [Full Text] [Related]
36. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease. Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245 [TBL] [Abstract][Full Text] [Related]
37. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration. Obulesu M; Somashekhar R; Venu R Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304 [TBL] [Abstract][Full Text] [Related]
38. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Hamley IW Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427 [No Abstract] [Full Text] [Related]
39. [The role of lipid metabolism in Alzheimer's disease]. Kamino K; Tanaka T; Kida T; Ohkochi M; Tanii H; Kudo T; Takeda M Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Aug; 22(4):103-10. PubMed ID: 12373863 [TBL] [Abstract][Full Text] [Related]